To validate the importance of LRP1 in mediating MC's migratory capacity towards glioma-derived PAI-1, a low-density lipoprotein (LDL) receptor family blocker, receptor associated protein (RAP) was used to block LRP1 in LAD2 cells. Here, LRP1 is linked to central nervous system cancer.